Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Mohan

Showing results (41-50 of 49) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 49 results.
Allergy|May 12, 2021
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposisGiorgio Walter Canonica, Tim W Harrison, Pascal Chanez, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 21, 2022
Biologic use and outcomes among adults with severe asthma treated by US subspecialistsReynold A Panettieri, Dennis K Ledford, Bradley E Chipps, et al.
Journal of Asthma and Allergy|October 14, 2024
Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE StudyDennis K Ledford, Warner W Carr, Wendy C Moore, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
Frontiers in Immunology|October 19, 2020
Matrix Metalloproteinase-12 Is Required for Granuloma ProgressionArjun Mohan, Nicole Neequaye, Anagha Malur, et al.
American Journal of Respiratory Cell and Molecular Biology|February 12, 2019
Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis ModelAnagha Malur, Arjun Mohan, Robert A Barrington, et al.
Annals of the American Thoracic Society|September 28, 2023
Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical TrialDavid H Au, Emily Gleason, Rachel Hunter-Merrill, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2023
Questions in Mild Asthma: An Official American Thoracic Society Research StatementArjun Mohan, Njira L Lugogo, Nicola A Hanania, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Pageof 5

Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Allergy|May 12, 2021
Benralizumab improves symptoms of patients with severe, eosinophilic asthma with a diagnosis of nasal polyposisGiorgio Walter Canonica, Tim W Harrison, Pascal Chanez, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 21, 2022
Biologic use and outcomes among adults with severe asthma treated by US subspecialistsReynold A Panettieri, Dennis K Ledford, Bradley E Chipps, et al.
Journal of Asthma and Allergy|October 14, 2024
Reduced Effectiveness of Anti-IgE Treatment Among Adults with Severe Asthma with Older Age of Asthma Onset: Results from the CHRONICLE StudyDennis K Ledford, Warner W Carr, Wendy C Moore, et al.
The Lancet. Respiratory Medicine|December 28, 2020
Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trialTim W Harrison, Pascal Chanez, Francesco Menzella, et al.
Frontiers in Immunology|October 19, 2020
Matrix Metalloproteinase-12 Is Required for Granuloma ProgressionArjun Mohan, Nicole Neequaye, Anagha Malur, et al.
American Journal of Respiratory Cell and Molecular Biology|February 12, 2019
Peroxisome Proliferator-activated Receptor-γ Deficiency Exacerbates Fibrotic Response to Mycobacteria Peptide in Murine Sarcoidosis ModelAnagha Malur, Arjun Mohan, Robert A Barrington, et al.
Annals of the American Thoracic Society|September 28, 2023
Lifestyle Intervention and Excess Weight in Chronic Obstructive Pulmonary Disease (COPD): INSIGHT COPD Randomized Clinical TrialDavid H Au, Emily Gleason, Rachel Hunter-Merrill, et al.
American Journal of Respiratory and Critical Care Medicine|June 1, 2023
Questions in Mild Asthma: An Official American Thoracic Society Research StatementArjun Mohan, Njira L Lugogo, Nicola A Hanania, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
Pageof 5